Skip to main content
Premium Trial:

Request an Annual Quote

Ambry, Academic Groups Partner to Create Hereditary Cancer Registry

NEW YORK (GenomeWeb) – Ambry Genetics and its collaborators today announced a partnership to create a hereditary cancer research registry leveraging next-generation sequencing.

Ambry and researchers from Memorial Sloan Kettering Cancer Center, Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania, Dana-Farber Cancer Institute, and other diagnostic testing laboratories announced the formation of the Prospective Registry of MultiPlex Testing (PROMPT), a research registry for people have used multigene panels. Through the registry, PROMPT partners aim to learn more about the genes on the panels that are associated with an increased risk of cancer, according to PROMPT's website.

In the initial phase of the collaboration, Ambry will provide test results from patients who have undergone hereditary cancer multiplex panel testing and been found to have pathogenic mutations or variants of unknown significance (VUS). Ambry will offer these individuals research opportunities to define the clinical significance of the mutations and VUS.

In collaboration with the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA), an international breast cancer research consortium, PROMPT seeks to define penetrance and genotype-phenotype associations.

"The study design is unique in that its goal is to reach thousands of mutation carriers, many of whom may never be seen at the types of academic or tertiary care centers where this type of clinical research is typically carried out," Ambry CMO Elizabeth Chao said in a statement. "This improves patient access as well as the applicability of the results to the general US population."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.